Show
Sort by
-
Comment on 'An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology'
-
- Journal Article
- A1
- open access
Vaccinations in patients receiving systemic drugs for skin disorders : what can we learn for SARS-Cov-2 vaccination strategies?
-
- Journal Article
- A1
- open access
Autoimmunity in segmental vitiligo
-
Comparison of methods to estimate the affected body surface area and the dosage of topical treatments in psoriasis and atopic dermatitis : the advantage of a picture‐based tool
-
Critical appraisal of the oxidative stress pathway in vitiligo : a systematic review and meta-analysis
-
Secukinumab : IL-17A inhibition to treat psoriatic arthritis
-
Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases
-
The biology of hyperpigmentation syndromes
-
- Journal Article
- A1
- open access
The distribution pattern of segmental vitiligo: clues for somatic mosaicism
-
The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients
-
Immune mediated mechanisms of melanocyte destruction: paving the way for efficient immunotherapeutic strategies against melanoma
-
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
-
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy
-
The haptoglobin phenotype determines the risk of cutaneous squamous cell carcinoma in kidney transplant patients
-
Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma
-
Acute generalized exanthematous pustulosis : an overview of the clinical, immunological and diagnostic concepts